Thomas Jefferson UniversitySidney Kimmel Medical College

Main menu:

Jefferson Vaccine Center


Jefferson Medical College established the Jefferson Vaccine Center (JVC) in 2007 with the goal of combining and further enhancing its existing interest and expertise in the area of Vaccine research and related areas such as immunology and microbial pathogenesis.

The Jefferson Vaccine Center will build on this strength in basic and translational research and offers faculty and researchers a forum for open discussions and builds a new meeting place in the Philadelphia area for researchers interested in vaccine development.


In the News

New Funding for JVC Members

Dr. McGettigan, was awarded a four-year $1.5 million R01 grant from the NIH to extend his exciting work on the development of a novel, safe, and effective rabies virus vaccine.

A Team of Researchers from Fox Chase, Jefferson and Penn State Receive NIAID Grant for Viral Control. Both Dr. Luis Sigal and Dr. Eisenlohr are members of the JVC. The team to receive a total of approximately $2 million each year for the next five years. For more information ...

Dr. David Abraham received a five year R01 grant to study the development of a recombinant vaccine against human onchocerciasis.

Read More